We investigated whether angiotensin II receptor blockers (ARBs) and angiotensin converting
enzyme inhibitors (ACE-Is) are more strongly associated with Alzheimer's disease (AD) …

Abstract See Moon (doi: 10.1093/awv239) for a scientific commentary on this article.
Traumatic brain injury frequently leads to long-term cognitive problems and physical …

Angiotensin II (AngII) receptor blockers that bind selectively AngII type 1 (AT1) receptors may
protect from Alzheimer's disease (AD). We studied the ability of the AT1 receptor antagonist …

The traditional renin-angiotensin system (RAS) is indispensable system in adjusting sodium
homeostasis, body fluid volume, and controlling arterial blood pressure. The key elements …

Background Antihypertensive treatments have been shown to reduce the risk of Alzheimer's
disease (AD). The renin-angiotensin system (RAS) has been implicated in AD, and thus …

Cerebral blood flow (CBF) is decreased and cognitive dysfunction develops in the advanced
stages of heart failure. However, few data are available regarding the factors associated with …

Aims Cognitive dysfunction is a prevalent condition among patients with heart failure, and is
independently associated with disability and mortality. Angiotensin-converting enzyme …

Objective This prospective, randomised, open-label, blinded-endpoint study was to compare
the effects of the angiotensin II (Ang II) AT1 receptor antagonist valsartan with those of the …

Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …

Clinical studies demonstrated a positive correlation between hypertension and cognitive
decline. Beneficial effects of angiotensin II receptor blockers on cognitive functions have …